Effect of Public Sector Antiretroviral Treatment Programme on Tuberculosis and Immunization Care
NCT ID: NCT00203762
Last Updated: 2007-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
39 participants
INTERVENTIONAL
2003-05-31
2006-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to compare the performance of tuberculosis (TB) and childhood immunization programmes in primary care facilities participating in the South African national antiretroviral treatment programme with those which have yet to be included in the ART programme.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This could lead to impaired performance in other priority programmes like childhood immunization while health workers are distracted by the demands of establishing and maintaining ART programmes. On the other hand, ART provisions may have positive spin-offs for related programmes like improved case detection of tuberculosis among HIV-positive patients seeking ART. The impact of the ART programme on primary healthcare more generally must be weighed against the benefits of providing antiretroviral treatment to those with AIDS.
Comparison: Primary care clinics in the Free State province, South Africa. 15 clinics participating in the first phases of the national ART programme will be compared with 24 clinics which have yet to be included in the national treatment programme. The unit of analysis will be the clinic although the outcome data will be collected from individual patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Public sector antiretroviral treatment programmes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intervention: 15 primary care clinics participating in the first phases of the national antiretroviral treatment programme
* Control: 24 primary care clinics yet to be included in the national antiretroviral treatment programme randomly selected after stratification for health district and ranking of clinic size.
Patients:
* All patients attending tuberculosis and childhood immunization programmes at the above 39 clinics one year before and one year after antiretroviral treatment services commenced in these facilities.
Exclusion Criteria
* Clinics earmarked for the second year of the rollout of the antiretroviral treatment programme.
Patients:
* None.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Free State Department of Health
UNKNOWN
Medical Research Council, South Africa
OTHER
Knowledge Translation Programme, University of Toronto
OTHER
Institute for Clinical Evaluative Sciences
OTHER
London School of Hygiene and Tropical Medicine
OTHER
University of the Western Cape
OTHER
University of Cape Town
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
L R Fairall, MBChB
Role: PRINCIPAL_INVESTIGATOR
University of Cape Town Lung Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Cape Town Lung Institute
Cape Town, Western Cape, South Africa
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
L R Fairall, MBChB
Role: primary
G M Rembe, BSc(Hons)
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IDRC 102770-001
Identifier Type: -
Identifier Source: org_study_id